Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06956781 · ClinicalTrials.gov registry record · NA
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
A NA study of PTSD and Trauma, sponsored by University of Rochester.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06956781: Recruiting NA study of PTSD and Trauma, sponsored by University of Rochester.
NCT06956781 is a NA study of PTSD and Trauma that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 200 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06956781, a NA study of PTSD and Trauma, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test the extent to which different treatment components work to improve pediatric post-traumatic stress disorder (PTSD). It will also provide evidence for how these components work. The main research questions are: What are the effects of different components used to treat PTSD? What do these components change to produce benefits in PTSD? Researchers will: Compare components to a psychological placebo to estimate their effects and measure how they work Examine how components work alone and in conjunction with other components Participants will: Receive different combinations of components and placebo Attend weekly treatment sessions Provide information to evaluate changes in PTSD
Primary Outcome
The CAPS-CA is a clinician-administered diagnostic interview measuring the severity of PTSD symptoms in the past month. The interview assesses 20 PTSD symptoms according to DSM-5 diagnostic criteria with each symptom rated on a severity scale ranging from 0 to 4. Ratings for each individual symptom are summed with higher scores indicating greater severities of PTSD symptoms (total scores range from 0-80).
Conditions Studied
Interventions
- BEHAVIORAL Emotion Regulation
- BEHAVIORAL Exposure
- BEHAVIORAL Cognitive Processing
- BEHAVIORAL Bi-lateral Stimulation
- BEHAVIORAL Psychological Placebo
Study Locations (1)
New York
- The Mt. Hope Family Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-01 |
| Est. Completion | 2028-08 |
| Phase | NA |
What NCT06956781 shows while recruiting
NCT06956781 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (34% lower).
The record links to 3 conditions, with PTSD appearing as the primary indexed condition, and to 5 interventions - of which Emotion Regulation is the first listed.
NCT06956781 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06956781 about?
NCT06956781 is a clinical study titled "Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)". The goal of this clinical trial is to test the extent to which different treatment components work to improve pediatric post-traumatic stress disorder (PTSD). It will also provide evidence for how these components work. The main research questions are: What are the effects of different components u...
What is the current status of trial NCT06956781?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2026-01. Estimated completion is 2028-08.
What conditions does trial NCT06956781 study?
This clinical trial studies the following conditions: PTSD, Trauma, Pediatric ALL.
What interventions are being tested in trial NCT06956781?
The interventions under investigation include: Emotion Regulation (BEHAVIORAL), Exposure (BEHAVIORAL), Cognitive Processing (BEHAVIORAL), Bi-lateral Stimulation (BEHAVIORAL), Psychological Placebo (BEHAVIORAL).
Who is sponsoring clinical trial NCT06956781?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06956781 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06956781's enrollment target sits among peer trials
200 28th of 154 higher than 126 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia